Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Amgen posts higher 3rd-quarter profit, sales rise 24%
04:03pm, Wednesday, 30'th Oct 2024
Amgen reported higher quarterly earnings on Wednesday, driven by a 24% rise in sales of products including cholesterol drug Repatha and Prolia for osteoporosis, and said results of a mid-stage trial o
AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
04:01pm, Wednesday, 30'th Oct 2024
THOUSAND OAKS, Calif. , Oct. 30, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2024.
2 Reliable Dividend Stocks You Can Buy and Hold Forever
04:30am, Saturday, 26'th Oct 2024
There are reasons beyond the dividends to invest in these stocks.
AMGEN ANNOUNCES 2024 FOURTH QUARTER DIVIDEND
04:00pm, Friday, 25'th Oct 2024
THOUSAND OAKS, Calif. , Oct. 25, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.25 per share dividend for the fourth quarter of 2024.
Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The List
10:29am, Friday, 25'th Oct 2024
Amgen Inc.'s Q3 earnings — due 30th October -are unlikely to be a major upside catalyst due to tricky comparisons, increased R&D spending, and transitional phase challenges. Key patents expiring on
Ahead of Amgen (AMGN) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:20am, Friday, 25'th Oct 2024
Besides Wall Street's top -and-bottom-line estimates for Amgen (AMGN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quar
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
10:01am, Friday, 25'th Oct 2024
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
AMGEN ANNOUNCES WEBCAST OF 2024 THIRD QUARTER FINANCIAL RESULTS
04:00pm, Thursday, 24'th Oct 2024
THOUSAND OAKS, Calif. , Oct. 24, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its third quarter 2024 financial results on Wednesday, October 30, 2024, after the close o
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Denosumab (Prolia & Xgeva) Biosimilars Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic informati
Amgen Gears Up to Report Q3 Earnings: Here's What to Expect
04:01pm, Wednesday, 23'rd Oct 2024
Volume growth from AMGN's key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.
Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:07am, Wednesday, 23'rd Oct 2024
Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amgen to launch US Eylea biosimilar after ruling in Regeneron patent case
03:09pm, Tuesday, 22'nd Oct 2024
Amgen will launch its biosimilar version of Regeneron's blockbuster eye care drug Eylea following a U.S. appeals court ruling in its favor on Tuesday, an Amgen spokesperson said.
Why Amgen (AMGN) Dipped More Than Broader Market Today
07:06pm, Monday, 21'st Oct 2024
Amgen (AMGN) reachead $316.74 at the closing of the latest trading day, reflecting a -1.53% change compared to its last close.
Is Amgen Stock a Buy?
07:32am, Friday, 18'th Oct 2024
This biotech leader could be poised to rally higher.
Amgen (AMGN) Rises As Market Takes a Dip: Key Facts
07:01pm, Tuesday, 15'th Oct 2024
Amgen (AMGN) closed at $325.09 in the latest trading session, marking a +0.14% move from the prior day.
